Screener
MiNK Therapeutics, Inc. INKT Q3 2025 earnings
Reported November 14, 2025 · Before market open
EPS-$0.65Beat by $0.21
EPS estimate-$0.86
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$1.6M
EPS estimate-$0.35
Versus estimates
Diluted EPS
FAQ
- When did MiNK Therapeutics, Inc. report Q3 2025 earnings?
- MiNK Therapeutics, Inc. (INKT) reported Q3 2025 earnings on November 14, 2025 before market open.
- What were MiNK Therapeutics, Inc.'s Q3 2025 revenue and EPS?
- MiNK Therapeutics, Inc. reported eps of $-0.65 for Q3 2025.
- Did MiNK Therapeutics, Inc. beat estimates in Q3 2025?
- EPS beat the consensus estimate of $-0.86 by $0.21.
- How did MiNK Therapeutics, Inc.'s Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 30.0% from $-0.50.
- Where can I find MiNK Therapeutics, Inc.'s Q3 2025 SEC filings?
- You can read the 10-Q periodic report (0001193125-25-282905) directly on SEC EDGAR. The filing index links above go to sec.gov.
